Zum Hauptinhalt springen

Buprenorphin

03. Mai 2026 | Buprenorphin

Association between extended-release buprenorphine adherence and reduced healthcare costs among insured patients with opioid use disorder.

Association between extended-release buprenorphine adherence and reduced healthcare costs among insured patients with opioid use disorder. Jerry M, Venkat D, Flynn C, Tran AT, Abdel-Sattar M, Mullen W, Lane C. Front Public Health. 2026…

03. Mai 2026 | Buprenorphin

More than a medication: The lived meaning and value of long-acting injectable buprenorphine.

More than a medication: The lived meaning and value of long-acting injectable buprenorphine. Donaldson SR, Dillon JF, Radley A. Drug Alcohol Depend Rep. 2026 Mar 6;19:100421. doi: 10.1016/j.dadr.2026.100421. PMID: 41859248; PMCID: PMC1…

22. März 2026 | Buprenorphin

Buprenorphine Oral Lyophilisate for Treatment of Opioid Use Disorder: Pharmacology and Clinical Efficacy.

Buprenorphine Oral Lyophilisate for Treatment of Opioid Use Disorder: Pharmacology and Clinical Efficacy. Soyka M, Bolz S. Pharmaceuticals (Basel). 2026 Feb 5;19(2):270. doi: 10.3390/ph19020270. PMID: 41754811; PMCID: PMC12944577. htt…

27. Februar 2026 | Buprenorphin

Emergency Department–Initiated Buprenorphine for Opioid Use Disorder: A Randomized Clinical Trial.

Emergency Department–Initiated Buprenorphine for Opioid Use Disorder: A Randomized Clinical Trial. D’Onofrio G, Herring AA, Hawk KF, et al. JAMA. Published online February 11, 2026. doi:10.1001/jama.2025.27019 Abstract https://jamane…

27. Februar 2026 | Buprenorphin

Successful Treatment of Opioid-Induced Hyperalgesia with Buprenorphine: A Case Report.

Successful Treatment of Opioid-Induced Hyperalgesia with Buprenorphine: A Case Report. Clements A, Kaster B, Hartfield P. WMJ. 2025;124(5):489-491. PMID: 41499624. https://wmjonline.org/wp-content/uploads/2025/124/5/489.pdf

22. Februar 2026 | Buprenorphin

Population-Level Health Benefits and Harms Associated With Buprenorphine/Naloxone vs Methadone.

Population-Level Health Benefits and Harms Associated With Buprenorphine/Naloxone vs Methadone. Enns B, Guerra-Alejos BC, Min JE, Carter A, Siebert U, Nosyk B. JAMA Netw Open. 2025 Dec 1;8(12):e2551337. doi: 10.1001/jamanetworkopen.202…

15. Februar 2026 | Buprenorphin

Spülen nicht Putzen. Sublinguales Buprenorphin schlägt auf die Zähne

Spülen nicht Putzen. Sublinguales Buprenorphin schlägt auf die Zähne Bereits 2022 hatte die FDA auf Grundlage von Fallmeldungen Alarm geschlagen, nun hat eine kanadisch/US-amerikanische Studie die Vermutungen bestätigt: Sublinguales Buprenorphin ka…

Weitere
akutelle Informationen
zu den Themengebieten